Calendar BioMarin Pharmaceutical Inc.

Equities

BMRN

US09061G1013

Market Closed - Nasdaq 04:00:00 2024-05-31 pm EDT 5-day change 1st Jan Change
75.07 USD +0.79% Intraday chart for BioMarin Pharmaceutical Inc. -0.60% -22.14%

Chart calendar BioMarin Pharmaceutical Inc.

f6b657865ff4d0fe2cc2740f3c3a85.PXnjjXbLWz-TqeI4_1N6t8DXWlC1NEeHxMjMF311dOg.ahOT_0aRPQ_h3pgNymEs1LHgPRjYbjLVpa6BTkQZNY5rTLvdLqoSdOfEjQ~711878e8d4232146083781e3222af704

Upcoming events on BioMarin Pharmaceutical Inc.

2024-07-29 Q2 2024 Earnings Release (Projected)
2024-10-22 Q3 2024 Earnings Release (Projected)
2025-02-19 Q4 2024 Earnings Release (Projected)
2025-04-22 Q1 2025 Earnings Release (Projected)

Past events on BioMarin Pharmaceutical Inc.

2024-05-21 12:00 pm Annual General Meeting
2024-05-15 01:00 pm BofA Securities Health Care Conference
2024-05-04 04:00 pm Pediatric Endocrine Society Meeting - Abstract Number : 6512
2024-05-03 01:15 pm Pediatric Endocrine Society Meeting - Abstract Number : 6831
2024-05-03 01:15 pm Pediatric Endocrine Society Meeting - Abstract Number : 6803
2024-05-03 01:15 pm Pediatric Endocrine Society Meeting - Abstract Number : 6822
2024-05-03 01:15 pm Pediatric Endocrine Society Meeting - Abstract Number : 6813
2024-04-24 04:30 pm Q1 2024 Earnings Call
2024-04-24 04:03 pm Q1 2024 Earnings Release
2024-03-15 10:30 am American College of Medical Genetics Meeting - Poster #: P144
2024-03-15 10:30 am American College of Medical Genetics Meeting - Poster #: P034
2024-03-14 01:30 pm American College of Medical Genetics Meeting - Oral Session: O03
2024-03-14 10:30 am American College of Medical Genetics Meeting - Poster #: P131
2024-03-14 10:30 am American College of Medical Genetics Meeting - Poster #: P139
2024-03-14 10:30 am American College of Medical Genetics Meeting - Poster #: P141
2024-03-14 10:30 am American College of Medical Genetics Meeting - Poster #: P049
2024-03-12 01:35 pm Barclays Global Healthcare Conference - Fireside Chat
2024-03-11 Jefferies Biotech on the Bay Summit
2024-03-11 10:40 am Leerink Partners Global Biopharma Conference - Fireside Chat
2024-03-05 12:50 pm TD Cowen Health Care Conference - Fireside Chat

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
1 704
1 708
-0.22%
1 860
1 851
0.53%
1 846
1 843
0.2%
2 096
2 096
-0.02%
2 419
2 412
0.31%

2 739

EBITDA
Million USD
Released
Forecast
Spread
4,84
1,92
151.64%
68,4
106
-35.65%
25,7
25,6
0.24%
252
234
7.3%
262
309
-14.96%

512

EBIT
Million USD
Released
Forecast
Spread
-100
-100,0
-0.47%
-36,8
-17,7
-107.38%
-82,3
-76,7
-7.4%
150
158
-5.08%
158
197
-19.91%

451

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-94,8
-95,0
0.15%
-42,3
-26,1
-61.91%
-75,4
-75,1
-0.29%
150
150
-0.48%
189
230
-18.18%

471

Net income
Million USD
Released
Forecast
Spread
-23,8
-53,0
55.01%
859
804
6.87%
-64,1
-67,7
5.3%
142
131
8.47%
168
190
-11.69%

364

EPS
USD
Released
Forecast
Spread
-0,13
-0,29
55.03%
4,53
4,24
6.94%
-0,35
-0,37
5.12%
0,75
0,68
9.89%
0,87
0,98
-11.21%

1,84

Announcement Date26/02/2025/02/2123/02/2227/02/2322/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
519
509
1.97%
534
522
2.27%
505
516
-2.04%
538
538
-0.13%
596
570
4.56%
595
595
0.01%
581
608
-4.35%
646
637
1.46%
649
652
-0.46%

664


693


740


738


756

EBITDA
Million USD
Released
Forecast
Spread
165
41,5
296.86%
64,4
55,8
15.49%
22,4
63,4
-64.72%
0,05
60,6
-99.91%
85,8
99,4
-13.71%



51,3


41,1
40,5
1.55%
116
90,7
27.64%

101


79,2


128







EBIT
Million USD
Released
Forecast
Spread
137
45,1
204.31%
39,2
30,7
27.55%
-2,42
10,7
-122.55%
-24,5
-4,85
-405.07%
59,3
40,0
48.39%
58,9
56,3
4.56%
25,7
45,7
-43.88%
14,2
50,9
-72.04%
88,5
78,3
12.91%

77,6


107


134


150


160

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
134
65,5
104.78%
34,9
25,9
34.35%
-1,90
2,90
-165.68%
-17,6
-11,7
-49.75%
56,8
28,8
96.93%
70,8
42,3
67.56%
41,7
52,7
-20.99%
19,3
55,9
-65.45%
106
72,1
46.43%

94,1


118


144


160


171

Net income
Million USD
Released
Forecast
Spread
121
56,5
113.91%
27,7
16,4
68.52%
-6,65
-0,74
-801.15%
-0,25
-12,2
97.95%
50,9
29,1
74.76%
56,0
42,5
31.76%
40,4
42,4
-4.73%
20,4
43,2
-52.79%
88,7
61,9
43.19%

73,1


93,6


112


119


130

EPS
USD
Released
Forecast
Spread
0,63
0,24
157.44%
0,15
0,09
66.57%
-0,04
0,00
-1008.03%
0,00
-0,07
-
0,27
0,15
76.85%
0,29
0,21
37.87%
0,21
0,22
-4.23%
0,11
0,22
-50.46%
0,46
0,33
40.75%

0,35


0,47


0,57


0,58


0,63

Announcement Date27/04/2203/08/2226/10/2227/02/2326/04/2331/07/2301/11/2322/02/2424/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BMRN Stock
  4. Calendar BioMarin Pharmaceutical Inc.